Cecilia A Brunello, Maria Merezhko, Riikka-Liisa Uronen, Henri J Huttunen
{"title":"Mechanisms of secretion and spreading of pathological tau protein.","authors":"Cecilia A Brunello, Maria Merezhko, Riikka-Liisa Uronen, Henri J Huttunen","doi":"10.1007/s00018-019-03349-1","DOIUrl":null,"url":null,"abstract":"<p><p>Accumulation of misfolded and aggregated forms of tau protein in the brain is a neuropathological hallmark of tauopathies, such as Alzheimer's disease and frontotemporal lobar degeneration. Tau aggregates have the ability to transfer from one cell to another and to induce templated misfolding and aggregation of healthy tau molecules in previously healthy cells, thereby propagating tau pathology across different brain areas in a prion-like manner. The molecular mechanisms involved in cell-to-cell transfer of tau aggregates are diverse, not mutually exclusive and only partially understood. Intracellular accumulation of misfolded tau induces several mechanisms that aim to reduce the cellular burden of aggregated proteins and also promote secretion of tau aggregates. However, tau may also be released from cells physiologically unrelated to protein aggregation. Tau secretion involves multiple vesicular and non-vesicle-mediated pathways, including secretion directly through the plasma membrane. Consequently, extracellular tau can be found in various forms, both as a free protein and in vesicles, such as exosomes and ectosomes. Once in the extracellular space, tau aggregates can be internalized by neighboring cells, both neurons and glial cells, via endocytic, pinocytic and phagocytic mechanisms. Importantly, accumulating evidence suggests that prion-like propagation of misfolding protein pathology could provide a general mechanism for disease progression in tauopathies and other related neurodegenerative diseases. Here, we review the recent literature on cellular mechanisms involved in cell-to-cell transfer of tau, with a particular focus in tau secretion.</p>","PeriodicalId":19075,"journal":{"name":"Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie","volume":"192 1","pages":"1721-1744"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190606/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1007/s00018-019-03349-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/10/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Accumulation of misfolded and aggregated forms of tau protein in the brain is a neuropathological hallmark of tauopathies, such as Alzheimer's disease and frontotemporal lobar degeneration. Tau aggregates have the ability to transfer from one cell to another and to induce templated misfolding and aggregation of healthy tau molecules in previously healthy cells, thereby propagating tau pathology across different brain areas in a prion-like manner. The molecular mechanisms involved in cell-to-cell transfer of tau aggregates are diverse, not mutually exclusive and only partially understood. Intracellular accumulation of misfolded tau induces several mechanisms that aim to reduce the cellular burden of aggregated proteins and also promote secretion of tau aggregates. However, tau may also be released from cells physiologically unrelated to protein aggregation. Tau secretion involves multiple vesicular and non-vesicle-mediated pathways, including secretion directly through the plasma membrane. Consequently, extracellular tau can be found in various forms, both as a free protein and in vesicles, such as exosomes and ectosomes. Once in the extracellular space, tau aggregates can be internalized by neighboring cells, both neurons and glial cells, via endocytic, pinocytic and phagocytic mechanisms. Importantly, accumulating evidence suggests that prion-like propagation of misfolding protein pathology could provide a general mechanism for disease progression in tauopathies and other related neurodegenerative diseases. Here, we review the recent literature on cellular mechanisms involved in cell-to-cell transfer of tau, with a particular focus in tau secretion.
tau蛋白在大脑中的错误折叠和聚集是阿尔茨海默病和额颞叶变性等tau病的神经病理学特征。Tau 蛋白聚集体能够从一个细胞转移到另一个细胞,并在先前健康的细胞中诱导健康的 Tau 蛋白分子模板化错误折叠和聚集,从而以类似朊病毒的方式在不同脑区传播 Tau 蛋白病理学。细胞间 tau 聚集体转移所涉及的分子机制多种多样,并不相互排斥,而且只得到了部分了解。折叠错误的 tau 在细胞内积聚会诱发多种机制,旨在减少聚集蛋白的细胞负担,同时促进 tau 聚集物的分泌。然而,tau 也可能从细胞中释放出来,这与蛋白质聚集的生理过程无关。Tau 的分泌涉及多种囊泡和非囊泡介导的途径,包括直接通过质膜分泌。因此,细胞外的 tau 可以以各种形式存在,既可以是游离蛋白,也可以是囊泡,如外泌体和外泌体。一旦进入细胞外空间,tau聚集体就会通过内吞、针刺和吞噬机制被邻近细胞(包括神经元和神经胶质细胞)内化。重要的是,越来越多的证据表明,错误折叠蛋白病理学的朊病毒样传播可能为tau病和其他相关神经退行性疾病的疾病进展提供了一种普遍机制。在此,我们回顾了有关细胞间 tau 转移的细胞机制的最新文献,尤其侧重于 tau 的分泌。